**Question:** Treatment of lepromatous leprosy:

A. Dapsone
B. Rifampicin
C. Clofazimine
D. Methotrexate

**Core Concept:** Leprosy is a chronic infectious disease caused by Mycobacterium leprae and M. lepromatosis. The disease is classified into two types: tuberculoid (TT) and lepromatous (LL). Lepromatous leprosy is characterized by widespread skin lesions, nerve damage, and potential for eye and respiratory involvement. Treatment aims to reduce bacterial load, control disease progression, and prevent complications.

**Why the Correct Answer is Right:**

The correct answer is Dapsone (A). Dapsone is a synthetic antibacterial agent that inhibits bacterial DNA synthesis by blocking the enzyme dihydrofolate reductase, leading to reduced folic acid synthesis and bacterial cell death. In the context of lepromatous leprosy, dapsone helps in reducing the bacterial load of Mycobacterium leprae and M. lepromatosis, thus controlling the disease progression and minimizing damage to nerves, eyes, and respiratory tract.

**Why Each Wrong Option is Incorrect:**

A. Rifampicin (B) is an effective antibiotic, but it is not specifically designed for the treatment of lepromatous leprosy. Dapsone, in combination with other drugs, is the mainstay of treatment for lepromatous leprosy.

C. Clofazimine (C) is primarily used as a part of multidrug therapy (MDT) for leprosy treatment, but it is not the primary drug for lepromatous leprosy treatment.

D. Methotrexate (D) is an immunosuppressive agent used in rheumatoid arthritis and other autoimmune disorders. It is not a suitable drug for treating lepromatous leprosy.

**Clinical Pearl:**

Multidrug therapy (MDT) is the standard treatment for leprosy, which includes a combination of Dapsone, Clofazimine, and Rifampicin. However, Dapsone is the primary drug for lepromatous leprosy due to its bactericidal effect on Mycobacterium leprae and M. lepromatosis. Although Rifampicin and Clofazimine are involved in MDT, their role is secondary to Dapsone's primary function in controlling bacterial load and preventing disease progression in lepromatous leprosy.